Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company building the category leader in Synergistic Precision Oncology, today announced it will hold a ...

At the event, GCCL will present a poster on the development and optimization of a Focus Reduction Neutralization Test (FRNT) assay for evaluating neutralizing antibody titers agai ...

Rollercoaster engineers, fisherman, tigers and butterflies all found a home at Southside Elementary last week during the ...

Metabolic profiling using Seahorse analysis showed that CCR5 inhibition reduced oxygen consumption rate (OCR) in a dose-dependent manner, consistent with modulation of glycolytic and metabolic ...

Presentations showcase progress in BioNTech's late-stage lung cancer programs, reinforcing the potential of the Company's differentiated portfolio spanning immunomodulators, antibody-drug conjugates, ...

A UNILAG student gained continental recognition for his AI research on antimicrobial resistance, ranking top 7% and finishing ...

Father Peter Wierzbicki, an r/AskAPriest moderator, created his Reddit account, u/polski-cygan, three years ago. Originally ...

Our bodies are our homes, yet when it comes to the kidneys, we readily accept an ambivalence toward anatomical understanding.

Dosed three cohorts in Phase 1 trial of STRO-004, potential best-in-class Tissue Factor (TF) ADC; on track to report initial clinical data in mid-2026 - - Company announced first wholly owned dual-pay ...

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) will present preclinical data on its experimental breast ...

On March 5, the halls of Fox Township Elementary School were busy as parents, grandparents and friends came to see fifth ...

Reddit.com is not typically a place most people think of venturing to when they need to ask a priest a question. But through ...